Skip to main content
logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.995
-0.025 (-0.83%)
May 14, 2026, 12:11 PM EDT - Market open

Altimmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
582400522795809376
Market Cap Growth
48.29%-23.27%-34.39%-1.76%115.53%-10.38%
Enterprise Value
284.44161.08389.73597.27624.42185.17
Last Close Price
3.003.617.2111.2516.459.16
PE Ratio
--3.61-5.38-6.78-9.09-3.90
PS Ratio
16152.169763.0926083.101866.48-11902.0085.15
PB Ratio
1.381.784.224.104.371.89
P/TBV Ratio
1.041.414.143.094.171.90
P/FCF Ratio
--5.93-6.53-10.48-12.91-4.16
P/OCF Ratio
--5.93-6.53-10.49-12.93-4.80
EV/Sales Ratio
7901.193928.6719486.501402.03-9182.7041.99
EV/EBITDA Ratio
--1.71-3.79-6.26-7.16-1.92
EV/EBIT Ratio
--1.70-3.78-6.23-7.12-1.91
EV/FCF Ratio
--2.38-4.88-7.87-9.96-2.05
Debt / Equity Ratio
0.120.150000
Debt / EBITDA Ratio
-0.36-0.36----
Debt / FCF Ratio
-0.48-0.51----
Net Debt / Equity Ratio
-1.05-1.06-1.07-1.02-1.00-0.96
Net Debt / EBITDA Ratio
3.072.541.282.072.121.98
Net Debt / FCF Ratio
4.143.541.652.612.952.11
Asset Turnover
0.000.000.000.000.000.02
Quick Ratio
29.4318.3512.9016.6910.9910.73
Current Ratio
29.5618.5513.1117.2611.3111.17
Return on Equity (ROE)
-35.80%-50.57%-59.86%-46.63%-44.07%-45.69%
Return on Assets (ROA)
-31.49%-45.42%-58.96%-45.95%-41.31%-41.78%
Return on Invested Capital (ROIC)
1223.63%1633.03%8408.48%-3425.42%-825.61%-578.92%
Return on Capital Employed (ROCE)
-32.90%-47.99%-63.04%-49.40%-44.94%-44.69%
Earnings Yield
-15.66%-27.70%-18.59%-14.76%-11.00%-25.66%
FCF Yield
--16.87%-15.31%-9.54%-7.75%-24.06%
Buyback Yield / Dilution
-38.98%-24.08%-33.35%-13.47%-13.67%-61.03%
Total Shareholder Return
-38.98%-24.08%-33.35%-13.47%-13.67%-61.03%
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q